After the publication of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study ([@B1]), the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) ([@B2]) formulated consensus guidelines for the testing and diagnosis of gestational diabetes mellitus (GDM). These have been adopted by the American Diabetes Association ([@B3]). The Ministry of Health (MOH) of China also recommended that new testing and diagnostic criteria based on the IADPSG guidelines ([@B4]) be effective beginning 1 December 2011. The Chinese criteria agree with the American Diabetes Association that a diagnostic 75-g oral glucose tolerance test (OGTT) should be performed between the 24th and 28th week of gestation for all pregnant women not previously known to have diabetes. A diagnosis of GDM can be made if one or more of the following glucose levels are elevated: fasting ≥5.1 mmol/L, 1 h ≥10.0 mmol/L, and 2 h ≥8.5 mmol/L.

This is the one-step approach that the MOH has recommended to well-resourced medical institutions. However, in China a formal OGTT may be difficult to implement in low-resourced rural areas. Therefore, and different from the American Diabetes Association, the MOH has recommended a two-step approach under these circumstances. A fasting plasma glucose can be used as a screening tool to reduce the number of OGTTs required. If the fasting plasma glucose is ≥5.1 mmol/L, GDM can be diagnosed and if \<4.4 mmol/L, GDM is unlikely. Women with a result of ≥4.4 and ≤5.0 mmol/L will still require a glucose tolerance test. This approach will approximately halve the number of glucose tolerance tests required ([@B5]).
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